Opioid Abuse Initiatives

NSA is actively involved in dealing with the opioid epidemic. If your office would like to be considered for small donations of Naloxone (Narcan ®) and you haven’t yet started a program, please contact Fred Wilson at fwilson@sheriffs.org.


On November 1, 2017, the White House announced the release of the Fentanyl Safety Recommendations for First Responders. The Recommendations provide first responders with unified, scientific, evidence-based recommendations to protect themselves when the presence of fentanyl is suspected. The National Sheriffs' Association supports the release of these Recommendations as a critical first step in keeping first responders safe in the field. The Recommendations are the result of a Federal Interagency Working Group coordinated by the White House National Security Council. Stakeholder associations and organizations representing the medical, public health, law enforcement, Fire/EMS, and occupational safety and health disciplines provided invaluable input to inform the Interagency Working Group’s efforts, and their feedback helped ensure the Recommendations are operationally relevant, appropriately tailored to first responders, and conveyed in a user-friendly one-page format. NSA is one of 24 associations/organizations offering collaborative support for the Recommendations.

Download "Fentanyl: Safety Recommendations for First Responders," or visit https://www.whitehouse.gov/ondcp/key-issues/fentanyl for more information.

Read more on Fentanyl from the Drug Enforcement Administration: https://www.dea.gov/druginfo/fentanyl.shtml

Handling of Suspected Drugs

NSA released two documents recently:


Diamond Pharmacy Services Releases "Naloxone Use in the Management of Opioid Overdose" in December 2017





Adapt Pharma® Launches Roll Call Training Video to Educate Law Enforcement on NARCAN® (naloxone HCI) Nasal Spray 4mg: Adapt Pharma, Inc. (www.adaptpharma.com) today launched a new roll call training video to educate law enforcement on proper administration of NARCAN® (naloxone HCI) Nasal Spray 4mg to help reverse the effects of an opioid overdose.  This roll call instructional video can be downloaded from Narcan.com/LawEnforcementTrainingVideo and customized to include a personalized introduction from law enforcement leadership.



Email release - Are your officers prepared for an accidental opioid emergency?

Frequently Asked Questions about Emergency Treatment for Opioid Overdose (for first responders)

NARCAN® (naloxone HCI) Nasal Spray Indications and Important Safety Information

During the NSA 2017 Annual Education and Technology Expo in Reno, Neveda, Judge Jeanine Pirro hosted a panel featuring Sheriff Keith Cain (Daviess County, KY), Corporal Michael "Duane" Harper (Daviess County, KY), and Dr. Gail Cawkwell, MD, PhD (Chief Medical Officer, Purdue Pharma). 




Original air date: April 13, 2017

Drug overdose is the leading cause of accidental death in the US, surpassing traffic fatalities. Opioid use is driving this epidemic. Awareness of prescription abuse and misuse has resulted in people turning to heroin. Heroin is being mixed with ultra potent chemicals and more people are accidentally overdosing and dying.

Opioids have a long history of medicinal and recreational use. They take away pain and activate pleasure sensors in the brain. Too much of an opiate can stop a person's breathing. Naloxone is an opiate receptor blocker that can restore a person's ability to breathe. It can be administered intranasal and can save a person's life. Naloxone is a safe medication that an officer can administer with training. In this webinar, learn how the benefits of an opioid reversal program go beyond just a life-saving intervention and truly embody law enforcement's motto "to protect and to serve".

Presenter: Christopher Cicuto, Clinical Staff Pharmacist, Drug Information Center, Diamond Pharmacy, Indiana, PA

View Recording.